A detailed history of Gamma Investing LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Gamma Investing LLC holds 782 shares of BMRN stock, worth $51,901. This represents 0.01% of its overall portfolio holdings.

Number of Shares
782
Previous 501 56.09%
Holding current value
$51,901
Previous $41.2 Million 33.26%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$69.02 - $93.84 $19,394 - $26,369
281 Added 56.09%
782 $55 Million
Q2 2024

Jul 02, 2024

BUY
$74.43 - $92.22 $8,261 - $10,236
111 Added 28.46%
501 $41.2 Million
Q1 2024

Apr 05, 2024

BUY
$83.81 - $99.0 $9,638 - $11,385
115 Added 41.82%
390 $34.1 Million
Q4 2023

Feb 01, 2024

BUY
$76.22 - $98.51 $20,960 - $27,090
275 New
275 $24.2 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.